Literature DB >> 11519151

[Selective serotonin reuptake inhibitor(SSRI)].

N Motohashi1.   

Abstract

Selective serotonin reuptake inhibitors(SSRIs) are safe antidepressants and now widely used for the treatment of depression. Although there are five SSRIs(citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline) available in the world, only two(fluvoxamine and paroxetine) are approved in Japan. SSRIs are also used for the treatment of obsessive-compulsive disorders, panic disorders, eating disorders and so on. Major side effects of SSRIs are gastrointestinal symptoms(especially nausea), neurological symptoms (particularly headache and tremor) and psychiatric symptoms(especially anxiety). While therapeutic effects of SSRIs seem to be related to desensitization of somatodendritic serotonin 1A autoreceptors in the raphe nuclei, other neurotransmitters and intracellular mechanisms may be also involved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519151

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  2 in total

1.  Successful treatment of treatment-resistant schizophrenia in a 10-year-catatonic patient by augmentation of selective serotonin reuptake inhibitors: a case report.

Authors:  Mei-Jung Chen; Shiau-Shian Huang; Kai-Dih Juang; Chin-Hong Chan
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

2.  A case report of schizoaffective disorder with ritualistic behaviors and catatonic stupor: successful treatment by risperidone and modified electroconvulsive therapy.

Authors:  Yuanhan Bai; Xi Yang; Zhiqiang Zeng; Haichen Yang
Journal:  BMC Psychiatry       Date:  2018-03-13       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.